Disbiotic changes in patients with non-alcoholic fatty liver disease
https://doi.org/10.33667/2078-5631-2019-4-38(413)-44-47
Abstract
The results of study at 96 patients with non-alcoholic fatty liver disease are presented. A high incidence of intestinal microbiome disorders was observed in the examined patients, especially at the stage of non-alcoholic steatohepatitis. The relationship between the persistence of impaired lipid metabolism and the degree of dysbiosis of the colon, namely between grade II dysbiosis and the level of total cholesterol in patients with non-alcoholic fatty hepatosis (r = 0.77; p < 0.01), and grade III dysbiosis and total cholesterol, triglycerides in patients with non-alcoholic fatty steatohepatitis.
About the Authors
E. S. Sirchak
Uzhgorod National University
Ukraine
Uzhgorod
Ukraine
Uzhgorod
V. I. Griga
Uzhgorod National University
Ukraine
Uzhgorod
Ukraine
Uzhgorod
Yo. I. Pichkar
Uzhgorod National University
Ukraine
Uzhgorod
Ukraine
Uzhgorod
N. Yu. Kurchak
Uzhgorod National University
Ukraine
Uzhgorod
Ukraine
Uzhgorod
References
1. A human gut microbial gene catalogue established by metagenomic sequencing MetaHIT Consortium / [J. Qin, R. Li, J. Raes et al.] // Nature. — 2010. № 4. — Р. 59–65.
2. Фадеенко Г. Д. Эффективность и безопасность адеметионина при коррекции функции печени у пациентов со стеатогепатитом. Результаты открытого сравнительного постмаркетингового исследования / Г. Д. Фадеенко, А. Е. Гриднев // Гастроентерологія. — 2018. — Том 52, № 2. — С. 27–34.
3. Asrih M. Inflammation as a potential link between nonalcoholic fatty liver disease and insulin resistance / M. Asrih, F. R. Jornayvaz // Journal of Endocrinology. — 2013. — Vol. 218 (3). — P. 25–36.
4. Buzzetti E. The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD) / E. Buzzetti, M. Pinzani, E. A. Tsochatzis // Metabolism. — 2016. — № 65. — Р. 1038–1048.
5. Elevated TCA cycle function in the pathology of diet-induced hepatic insulin resistance and fatty liver / [S. Satapati, N. E. Sunny, B. Kucejova et al.] // Journal of Lipid Research. — 2012. — Vol. 53 (6). — P. 1080–1092.
6. EASL–EASD–EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease / European Association for the Study of the Liver (EASL), European Association for the Study of Diabetes (EASD) and European Association for the Study of Obesity (EASO) // Journal of Hepatology. — 2016. — V. 64. — P. 1388–1402.
Review
For citations:
Sirchak E.S., Griga V.I., Pichkar Y.I., Kurchak N.Yu. Disbiotic changes in patients with non-alcoholic fatty liver disease. Medical alphabet. 2019;4(38):44-47. (In Russ.) https://doi.org/10.33667/2078-5631-2019-4-38(413)-44-47
Views:
353
Email this article 